# Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

> **NCT05084118** · PHASE3 · UNKNOWN · sponsor: **Medical University of Vienna** · enrollment: 164 (estimated)

## Conditions studied

- Atrial Fibrillation
- Postoperative Complications

## Interventions

- **DRUG:** Landiolol HCl
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05084118
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-21
- **Primary completion:** 2023-11-01
- **Final completion:** 2024-06-01
- **Target enrollment:** 164 (ESTIMATED)
- **Last updated:** 2021-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05084118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05084118, "Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05084118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*